Effects of enteric bacterial and cyanobacterial lipopolysaccharides, and of microcystin-LR, on glutathione S-transferase activities in zebra fish (Danio rerio)

被引:143
作者
Best, JH [1 ]
Pflugmacher, S
Wiegand, C
Eddy, FB
Metcalf, JS
Codd, GA
机构
[1] Univ Dundee, Dept Appl & Environm Biol, Sch Life Sci, Dundee DD1 4HN, Scotland
[2] Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany
关键词
microcystin-LR; lipopolysaccharide (LPS); cyanobacteria; zebra fish; detoxication enzymes; glutathione S-transferase (GST);
D O I
10.1016/S0166-445X(02)00010-3
中图分类号
Q17 [水生生物学];
学科分类号
071004 ;
摘要
Cyanobacteria (blue-green algae) can produce a variety of toxins including hepatotoxins e.g. microcystins, and endotoxins such as lipopolysaccharides (LPS). The combined effects of such toxins on fish are little known. This study examines the activities of microsomal (in) and soluble (s) glutathione S-transferases (GST) from embryos of the zebra fish, Danio rerio at the prim six embryo stage, which had been exposed since fertilisation to LPS from different sources. A further aim was to see how activity was affected by co-exposure to LPS and microcystin-LR (MC-LR). LPS were obtained from Salmonella typhimurium, Escherichia coli, a laboratory culture of Microcystis CYA 43 and natural cyanobacterial blooms of Microcystis and Gloeotrichia. Following in vivo exposure of embryos to each of the LPS preparations, mGST activity was significantly reduced (from 0.50 to between 0.06 and 0.32 nanokatals per milligram (nkat mg(-1)) protein). sGST activity in vivo was significantly reduced (from 1.05 to between 0.19 and 0.22 nkat mg(-1) protein) after exposure of embryos to each of the cyanobacterial LPS preparations, but not in response to S. typhimurium or E. coli LPS. Activities of both m- and sGSTs were reduced after co-exposure to MC-LR and cyanobacterial LPS, but only mGST activity was reduced in the S. typhimurium and E. coli LPS-treated embryos. In vitro preparations of GST from adult and prim six embryo D. rerio showed no significant changes in enzyme activity in response to the LPS preparations with the exception of Gloeotrichia bloom LPS, where mGST was reduced in adult and embryo preparations. The present study represents the first investigations into the effects of cyanobacterial LPS on the phase-II microcystin detoxication mechanism. LPS preparations, whether from axenic cyanobacteria or cyanobacterial blooms, are potentially capable of significantly reducing activity of both the s- and mGSTs, so reducing the capacity of D. rerio to detoxicate microcystins. The results presented here have wide ranging implications for both animal and human health. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 30 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
Carmichael WW, 1997, ADV BOT RES, V27, P211
[3]   Lipopolysaccharide inhibition of rat hepatic microsomal epoxide hydrolase and glutathione S-transferase gene expression irrespective of nuclear factor-κB activation [J].
Choi, SH ;
Kim, SG .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (11) :1427-1436
[4]  
Codd G A, 1997, Arch Toxicol Suppl, V19, P399
[5]   THE INVOLVEMENT OF KUPFFER CELLS IN CARBON-TETRACHLORIDE TOXICITY [J].
EDWARDS, MJ ;
KELLER, BJ ;
KAUFFMAN, FC ;
THURMAN, RG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 119 (02) :275-279
[6]   Drinking in freshwater-adapted rainbow trout fry, Oncorhynchus mykiss (Walbaum), in response to angiotensin I, angiotensin II, angiotensin-converting enzyme inhibition, and receptor blockade [J].
Fuentes, J ;
Eddy, FB .
PHYSIOLOGICAL ZOOLOGY, 1996, 69 (06) :1555-1569
[7]   ROLE OF INTERLEUKIN-1 IN THE DEPRESSION OF LIVER DRUG-METABOLISM BY ENDOTOXIN [J].
GHEZZI, P ;
SACCARDO, B ;
VILLA, P ;
ROSSI, V ;
BIANCHI, M ;
DINARELLO, CA .
INFECTION AND IMMUNITY, 1986, 54 (03) :837-840
[8]   RECOMBINANT TUMOR-NECROSIS-FACTOR DEPRESSES CYTOCHROME P450-DEPENDENT MICROSOMAL DRUG-METABOLISM IN MICE [J].
GHEZZI, P ;
SACCARDO, B ;
BIANCHI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 136 (01) :316-321
[9]  
HABIG WH, 1974, J BIOL CHEM, V249, P7130
[10]  
HEWETT JA, 1993, PHARMACOL REV, V45, P381